Global Tyrosine Kinase Inhibitors Market Assessment, By Mode of Binding [Type I Inhibitors, Type II Inhibitors, Type III Inhibitors, Type IV Inhibitors, Type V Inhibitors], By Type [Non-Receptor Tyrosine Kinase Inhibitors, Receptor Tyrosine Kinase Inhibitors, Multikinase Inhibitors, Serine/Threonine Kinase Inhibitors, Protein Kinase C Inhibitors, RHO Kinase Inhibitors, Others], By Application [Chronic Myeloid Leukemia, Lung Cancer, Breast Cancer, Renal Cell Cancer, Others], By End-user [Hospitals, Research Centers, Others], By Region, Opportunities and Forecast, 2017-2031F